Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
28 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 21 March 2022 and 25 March 2022 Download
21 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 14 March 2022 and 18 March 2022 Download
14 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 7 March 2022 and 11 March 2022 Download
07 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 28 February 2022 and 4 March 2022 Download
28 Feb 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 23 February 2022 and 25 February 2022 Download

Pages

Date Title Description PDF
06 Apr 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2017 Download
13 Mar 2017 Otros sobre negocio y situación financiera The Company releases the presentation related to its biosimilar of Enoxaparin Download
07 Mar 2017 Otros sobre negocio y situación financiera ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome Download
16 Feb 2017 Otros sobre Gobierno Corporativo The Company informs about the agreements adopted by the Board of Directors Download
16 Feb 2017 Informe anual de remuneraciones de los consejeros ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors Download

Pages